Diabeets.in > News > Uncategorized > Farxiga improved symptom burden and health-related quality of life in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial – AstraZeneca
Diabeets
07/11/2022
0
6
Farxiga improved symptom burden and health-related quality of life in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial – AstraZeneca